Interventional Radiology Laboratory, Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, United States.
Int J Cardiol. 2013 Apr 30;165(1):93-9. doi: 10.1016/j.ijcard.2011.07.096. Epub 2011 Aug 27.
Coronary filtration devices showed inadequate protection during PCI due to the inability to filter microemboli <120 μm in diameter. The purpose of this study was to determine the impact of two volumes of <120 μm microemboli on LV function, perfusion and viability using magnetic resonance imaging (MRI).
Under X-ray guidance, pigs (n = 18) received two different volumes (16 mm(3) or 32 mm(3)) of 40-120 μm microemboli (intracoronary). At 3 days, regional myocardial perfusion and LV function were assessed using first pass perfusion and cine MRI. Viability MRI was performed in beating and non-beating hearts to delineate microinfarcts and compare with histochemical triphenyltetrazolium chloride stain, using semi-automatic threshold method. Histology and cardiac injury enzymes were used to confirm the presence of microinfarcts and characterize cellular and vascular changes.
Microinfarcts were visible as enhanced specks on DE-MRI in all animals that received 32 mm(3), but only two-third of the animals that received 16 mm(3), volume. The decline in ejection fraction and increase in LV volumes and microinfarcts were volume dependent. Regional perfusion and contractility were significantly reduced in the LAD territory compared with remote myocardium. Histology showed apoptosis, edema, inflammation and vascular thrombosis.
Microemboli of <120 μm have deleterious effects on LV function, perfusion and viability and the effects are dependent on microemboli volume. Microinfarct visualization is crucial to ensure that myocardial dysfunction is related to dislodged microemboli and not only to pre-procedural stunning or hibernation. This noninvasive MRI method may help in evaluating the effectiveness of coronary filtration devices in protecting myocardium from microemboli.
由于不能过滤直径<120μm 的微栓子,冠状动脉过滤装置在 PCI 期间的保护作用不足。本研究旨在通过磁共振成像(MRI)确定两种体积<120μm 的微栓子对左心室功能、灌注和活力的影响。
在 X 射线引导下,猪(n=18)接受两种不同体积(16mm3 或 32mm3)的 40-120μm 微栓子(冠状动脉内)。在 3 天时,通过首过灌注和电影 MRI 评估局部心肌灌注和 LV 功能。利用在搏动和非搏动心脏上进行的 MRI 评估存活能力,以描绘微梗死,并与组织化学三苯基四唑氯染色进行比较,使用半自动阈值方法。利用组织学和心脏损伤酶来确认微梗死的存在,并对细胞和血管变化进行特征描述。
在所有接受 32mm3 体积微栓子的动物中,DE-MRI 上可见增强的斑点显示微梗死,但只有三分之二接受 16mm3 体积微栓子的动物可见。射血分数下降以及 LV 体积和微梗死的增加与体积有关。与远隔心肌相比,LAD 区域的灌注和收缩力明显降低。组织学显示凋亡、水肿、炎症和血管血栓形成。
<120μm 的微栓子对 LV 功能、灌注和活力有有害影响,且其影响与微栓子体积有关。微梗死的可视化对于确保心肌功能障碍与脱落的微栓子有关至关重要,而不仅仅与术前的局部缺血性心肌损伤或冬眠有关。这种非侵入性 MRI 方法可能有助于评估冠状动脉过滤装置在保护心肌免受微栓子侵害方面的有效性。